The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sorafenib     Quarter: 2016Q3

Total Records: 167     Number of Pages: 9

DRUGNAME PT EventCount
SORAFENIB (RAF KINASE INHIBITOR) Haematuria 1
SORAFENIB (RAF KINASE INHIBITOR) Hepatic vein stenosis 1
SORAFENIB (RAF KINASE INHIBITOR) Hyperthyroidism 1
SORAFENIB (RAF KINASE INHIBITOR) Hypogammaglobulinaemia 1
SORAFENIB (RAF KINASE INHIBITOR) Hypothyroidism 1
SORAFENIB (RAF KINASE INHIBITOR) Lymphadenitis bacterial 1
SORAFENIB (RAF KINASE INHIBITOR) Myocardial infarction 1
SORAFENIB (RAF KINASE INHIBITOR) Nephrotic syndrome 1
SORAFENIB (RAF KINASE INHIBITOR) Pain 1
SORAFENIB (RAF KINASE INHIBITOR) Proteinuria 1
SORAFENIB (RAF KINASE INHIBITOR) Rash maculo-papular 1
SORAFENIB (RAF KINASE INHIBITOR) Salivary gland cancer 1
SORAFENIB (RAF KINASE INHIBITOR) Squamous cell carcinoma of lung 1
SORAFENIB (RAF KINASE INHIBITOR) Thrombotic microangiopathy 1
SORAFENIB (RAF KINASE INHIBITOR) Tracheo-oesophageal fistula 1
SORAFENIB (RAF KINASE INHIBITOR) Venoocclusive liver disease 1
SORAFENIB, 200 MG Lipase increased 1
SORAFENIB, 200 MG BAYER Lipase increased 1
SORAFENIB, 200 MG BAYER Odynophagia 1
SORAFENIB, 200 MG BAYER Oedema 1

Total Records: 167     Number of Pages: 9